Urban Tea Inc. (NASDAQ: MYT) shares are -71.94% down in the year-to-date (YTD) period and have moved -4.23% or -$0.08 lower in the latest trading session. However, stock’s trailing 12-month performance remains nearly +4.02% lower. Comparatively, the stock is -87.60% down YTD and -69.32% over the trailing 3-month period. If we look at the shorter duration, its week performance is -36.02% and -58.39% over the month.
0 recommend buying, with 0 rating it as an Overweight.
EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT), on the other hand, is trading around $0.54 with a market cap of $69.34M and analyst research firms have a negative stance on its shares. Some analysts are even forecasting -$0.36 per share in earnings this year on a short term (1 year) basis.
Let us briefly look at the EyePoint Pharmaceuticals Inc. (EYPT) financials, with a focus on its operating details as indicated in its earnings report for the last quarter.
Company balance sheet and cash flow
EYPT’s operating expenses over the recent quarter were at $15.27 million. This represented a -270.55% of the company’s total revenues which amounted $4.12 million. With this in place, we can see that the company’s diluted EPS declined -$0.10 on the year-over-year period, shrinking to -$0.11 as given in the last earnings report.
In terms of the balance sheet & cash flow as of (Sep 2020), the total assets figure advanced to $69.69 million from $80.29 million over the previous quarter. The cash flow from operating activities totaled -$21.47 million, significantly higher than the -$30.44 million reported in the year-ago quarter. The company’s free cash flow for the quarter was -$21.51 million.
Insiders have transacted a total of 14 times at EyePoint Pharmaceuticals Inc. over the last 6 months, with insider purchases undertaken 10 times and accounting for 433,967 shares. Insider sales totaled 33,213 shares over the same period, with these deals completed in 4 transactions. Looking at these numbers, we realize that net purchases over that period are 6.0 shares. Insiders now hold a total of 1.03M shares after the latest sales, with 72.70% net shares purchased.
Insiders own 0.70% of the company shares, while shares held by institutions stand at 48.80% with a share float percentage of 123.92M. Investors are also buoyed by the number of investors in a company, with EyePoint Pharmaceuticals Inc. having a total of 93 institutions that hold shares in the company. The top two institutional holders are Essex Woodlands Management Inc. with over 41.91 million shares worth more than $31.73 million. As of Jun 29, 2020, Essex Woodlands Management Inc. held 33.47% of shares outstanding.
The other major institutional holder is HighTower Advisors, LLC, with the investment firm holding over 5.28 million shares as of Jun 29, 2020. The firm’s total holdings are worth over $4.0 million and represent 4.22% of shares outstanding.